• 15 November 2017

    Juno Therapeutics Explores CAR-T Trial Deaths

    At the Society for Immunotherapy for Cancer (SITC) meeting in National Harbor, Maryland this weekend, Juno Therapeutics presented findings from their investigation into the circumstances surrounding the patient deaths linked...

  • 15 November 2017

    MyCite: The first pill with digital tracking system

    The FDA has approved Abilify MyCite (aripiprazole) as the first drug with a digital tracking system, in a groundbreaking move that ensures patients suffering from mental illness take the medication...

  • 9 November 2017

    Cystic fibrosis: matching medicines with mutations

    The 2017 North American Cystic Fibrosis Conference (NACFC) was held at the Indiana Convention Center in Indianapolis, Indiana from November 2–4. The conference annually brings together scientists, clinicians, and caregivers...

  • 2 November 2017

    Number of pipeline drugs in the US by therapy area

    Oncology drugs are clearly the focus of development going into the future, while drugs for infectious disease and central nervous system also make up a large proportion of R&D spend.

  • 1 November 2017

    Ono Pharmaceutical shows strength in strategic alliance deals

    A lucrative licensing agreement deal was announced on 12 October between US-based Karyopharm Therapeutics and Japan’s Ono Pharmaceutical for the development and commercialization of Karyopharm’s lead novel compound selinexor and...

  • 1 November 2017

    Fierce competition amongst checkpoint inhibitor developers

    Checkpoint inhibitors, the latest strategy in cancer immunotherapy have shown promising results in treating several oncology indications including a range of solid tumor types such as melanoma and non-small cell...